CollPlant Biotechnologies Ltd.
CLGN
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3Dā¦ read more
Healthcare
Biotechnology
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.99
Price-8.72%
-$0.19
1Y
Price
Market Cap
$22.981m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-1647.5%
EBITDA Margin-1869.8%
Net Profit Margin-1374.5%
Free Cash Flow MarginRevenue
$2.402m
+366.4%
1y CAGR+1278.8%
3y CAGR+934.6%
5y CAGREarnings
-$13.003m
+21.7%
1y CAGR-18.9%
3y CAGR-1063.2%
5y CAGREPS
-$1.13
+22.1%
1y CAGR-17.5%
3y CAGR-1304.8%
5y CAGRBook Value
$12.505m
$17.437m
Assets$4.932m
Liabilities$3.027m
DebtDebt to Assets
17.4%
-0.2x
Debt to EBITDAFree Cash Flow
-$10.747m
+26.3%
1y CAGR-63.5%
3y CAGR-484.2%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company